SILO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Silo Pharma Inc (SILO) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of positive financial performance, absence of significant trading trends, and no recent news or catalysts make this stock less appealing for long-term growth. While technical indicators show some positive momentum, it is insufficient to justify a buy recommendation at this time.
The MACD is positive and expanding, indicating bullish momentum. RSI is at 66.779, which is neutral but nearing overbought levels. Moving averages are converging, showing no clear trend. The stock is trading near its R1 resistance level of 0.387 in pre-market, suggesting limited immediate upside potential.
No significant positive catalysts identified. Technical indicators show slight bullish momentum.
No recent news, no significant trading trends from hedge funds or insiders, and weak financial performance with declining EPS and gross margin.
In Q3 2025, revenue remained flat YoY at 18,025. Net income improved by 19.55% YoY but remains negative at -1,110,438. EPS dropped significantly by -45.45% YoY to -0.12. Gross margin deteriorated sharply to -14.77%, down -116.07% YoY. Overall, financial performance is weak.
No analyst rating or price target changes available.
